Abeona Therapeutics Appoints New SVP of Regulatory Affairs

Abeona Therapeutics Inc. has appointed Victor Paulus, Ph.D. as senior vice president, Regulatory Affairs. The Company also named Jodie Gillon, M.P.H. as vice president of Patient Advocacy and Clinical Affairs. Both Dr. Paulus and Ms. Gillon are reporting to Chief Executive Officer João Siffert, M.D.

"The addition of these seasoned industry leaders will strengthen our relationships with key stakeholders toward the successful development of our therapies," said Dr. Siffert. "Victor will lead us through the evolving regulatory landscape in close collaboration with the development, CMC, and quality teams as we close in on near-term milestones and prepare to bring new gene and cell therapies to patients. He has a proven track record of shaping preclinical and clinical regulatory strategies and securing product approvals."

"Jodie brings a unique blend of knowledge, broad experience and empathy to reference as she leads patient advocacy and clinical affairs for Abeona. Her qualifications are critical as we advance the development of potentially transformative therapies for serious rare diseases in close collaboration with patients and their families, and internal and external medical and scientific stakeholders," added Dr. Siffert. 

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com